Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Photobiomodulation and Tooth Analgesia

NCT06691269 · View on ClinicalTrials.gov ↗

Study Summary

The purpose of this study is to test photobiomodulation (PBM) with a non-invasive light device for reducing discomfort during dental treatments in children. We plan to conduct a series of three clinical studies in 200 school-aged children requiring routine dental treatment. The first study aims to test if PBM works for tooth and soft tissue by assessing response to cold testing and probing of gums. The second study aims to test if use of PBM on soft tissues before injection reduces discomfort. The third study aims to test if PBM can be used to do simple dental fillings in baby teeth without numbing injection.

Interventions

  • DEVICE Photobiomodulation
  • DRUG Topical Benzocaine
  • DRUG Local Anesthesia

Study Locations (1)

Maryland

  • University of Maryland School of Dentistry, Pediatric Clinics — Baltimore

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-07-07
Est. Completion 2027-06
Phase NA

Sponsor

University of Maryland, Baltimore

559 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06691269

The ClinicalTrials.gov registry entry for NCT06691269 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 559 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Dental Pain appearing as the primary indexed condition, and to 3 interventions — of which Photobiomodulation is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06691269 reports 1 study location spanning 1 distinct geographic area — top geographies include Maryland. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06691269 about?

NCT06691269 is a clinical study titled "Photobiomodulation and Tooth Analgesia". The purpose of this study is to test photobiomodulation (PBM) with a non-invasive light device for reducing discomfort during dental treatments in children. We plan to conduct a series of three clinical studies in 200 school-aged children requiring routine dental treatment. The first study aims to t...

What is the current status of trial NCT06691269?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-07-07. Estimated completion is 2027-06.

What conditions does trial NCT06691269 study?

This clinical trial studies the following conditions: Dental Pain, Dental Anaesthesia, Dental Analgesia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06691269?

The interventions under investigation include: Photobiomodulation (DEVICE), Topical Benzocaine (DRUG), Local Anesthesia (DRUG). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06691269?

This trial is sponsored by University of Maryland, Baltimore, which has 559 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06691269 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial